Work

BRAF Fusion as Resistance Mechanism to Osimertinib in EGFR-Mutated NSCLC: A Case Report and Review of Literature

Year: 2025

Type: article

Abstract: fusions as an acquired resistance mechanism to osimertinib and potential treatment strategies.

Source: JTO Clinical and Research Reports

DOI: 10.1016/j.jtocrr.2025.100867

Authors: Marianna Peroni, Alessandro Leonetti, Roberta Minari, Michela Verzè, Letizia Gnetti, Lorena Bottarelli, Cinzia Azzoni, Marco Galaverni, Nicola Simoni, Gabriele Missale, Elisabetta Biasini, Marcello Tiseo

Institutions: University of Parma, Ospedale di Parma

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,000

OpenAlex ID: W4411437379

FWCI: 1.174

Cites: 17

Cited by: 2

Related to: 10